Emerging Stocks Down Under 1 December 2020: Plexure, Actinogen Medical, PKS Holdings

Emerging Stocks Down Under: Plexure, Actinogen Medical, PKS Holdings

Plexure: There’s an app for that

In today's edition of Emerging Stocks Down Under, headquartered in Auckland New Zealand, Plexure is one of the more recent NZX-listed companies to do a secondary share offering on the ASX. The company’s listing went live on the 25 November 2020. Plexure produces a highly niche loyalty app, specifically designed for Quick Service Restaurants and grocery stores. The company was profitable during FY19 and is currently making the choice to funnel its cash into development and growth, likely resulting in a net loss this year. The question is, is it worth it?

Also in today's edition, a look at drug developer Actinogen Medical (ASX: ACW) and healthcare systems developer PKS Holdings (ASX: PKS).

Get access to all editions through a 30-day FREE TRIAL. No credit card required and the trial expires automatically.

SUBSCRIBE NOW

Click here to read the previous edition of Emerging Stocks Down Under published 24 November 2020

For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter

Please register or upgrade your plan to access this content.

Save $$$
30-Day Free Trial
$0
No Credit Card Required!
Get access to 4 publications
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks
Profit Premium
$69
Get access to 4 publications
Access to the full research Archive
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks
30-Day Free Trial
$0
No Credit Card Required!
Get access to 4 publications
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks
Profit Premium
$59
BILLED ANNUALLY
Get access to 4 publications
Access to the full research Archive
Weekly Investor Webinar
Access to Marc & Stuart's Top Picks